Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients - an Observational Study (REBUS)

NCT01102933 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT01102933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01102933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients - an Observational Study (REBUS)
Lead sponsor
Uppsala University
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
August 31, 2012
Enrollment
425 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction